The European Union and pharmaceutical company AstraZeneca have reached an agreement after a dispute on Covid-19 vaccine delivery schedules, announced a spokesperson.
The settlement will ensure the delivery of the remaining vaccine doses still due to EU member states, and put an end to a lawsuit that the EU had launched against the pharmaceutical company before the Brussels Court, explained the European Commission Spokesperson for Health.
By the end of the third quarter, 60 million doses will be delivered, and 75 million more by the end of the fourth quarter.
Another delivery of 65 million doses is scheduled before the end of March 2022. The company had already delivered 100 million doses to EU member states by June.
The settlement provides a “firm commitment” by the company to honor the delivery schedule, and includes a capped rebate system in case it falls behind once again.